Corcept Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Annual) Analysis

Corcept Therapeutics, Inc. (CORT)

44.05 +2.75 (+6.66%) USD | NASDAQ | Jan 23, 16:00

43.95 -0.10 (-0.23%) After-Hours: 17:58

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) for CORT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Benchmarks

Start Trial

Axsome Therapeutics, Inc.	Upgrade
Johnson & Johnson	Upgrade
United Therapeutics Corp.	--
Ultragenyx Pharmaceutical, Inc.	Upgrade
Amicus Therapeutics, Inc.	Upgrade